[TEVA] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[TEVA] Teva Pharmaceutical Industries Limited
Announcement Date
10-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -2,280.36%
YoY- -667.92%
Quarter Report
TEVA's Result
TEVA's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 3,850,000 3,878,000 3,661,000 3,884,000 3,595,000 3,785,000 3,661,000 3.40%
PBT 75,000 -914,000 -258,000 -1,100,000 166,000 -1,160,000 -971,000 -
Tax -12,000 -16,000 -19,000 154,000 107,000 -900,000 2,000 -
NP 80,000 -863,000 -205,000 -1,221,000 56,000 -232,000 -955,000 -
Tax Rate 16.00% - - - -64.46% - - -
Total Cost 3,770,000 4,741,000 3,866,000 5,105,000 3,539,000 4,017,000 4,616,000 -12.61%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin 2.08 -22.25 -5.60 -31.44 1.56 -6.13 -26.09 -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS 0.07 -0.77 -0.18 -1.10 0.05 -0.21 -0.86 -
EPS Diluted 0.07 -0.77 -0.18 -1.10 0.05 -0.21 -0.86 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.